| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jelena Levi | |
| Zhen Cheng | |||
| Zheng Miao | |||
| P2860 | cites work | Properties, production, and applications of camelid single-domain antibody fragments | Q24676749 |
| Selection and identification of single domain antibody fragments from camel heavy-chain antibodies | Q28250517 | ||
| High-affinity binders selected from designed ankyrin repeat protein libraries | Q28257550 | ||
| Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D. | Q30164292 | ||
| Engineering of a femtomolar affinity binding protein to human serum albumin | Q30844011 | ||
| Designing scaffolds of peptides for phage display libraries | Q30866411 | ||
| Use of phage display to probe the evolution of binding specificity and affinity in integrins | Q30901420 | ||
| In vitro evolution of the binding specificity of neocarzinostatin, an enediyne-binding chromoprotein. | Q30928342 | ||
| Directed evolution of high-affinity antibody mimics using mRNA display | Q31106575 | ||
| Searching sequence space for high-affinity binding peptides using ribosome display | Q31142727 | ||
| Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteins | Q31162756 | ||
| Alpha-amylase inhibitors selected from a combinatorial library of a cellulose binding domain scaffold | Q31813824 | ||
| Binding proteins from alternative scaffolds | Q33204931 | ||
| Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage | Q33208090 | ||
| A new generation of protein display scaffolds for molecular recognition | Q33230194 | ||
| Tumor imaging using a picomolar affinity HER2 binding affibody molecule | Q33240101 | ||
| Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro | Q33244398 | ||
| In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules | Q40164996 | ||
| 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. | Q40286486 | ||
| Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors | Q40309341 | ||
| Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold | Q43273120 | ||
| The Nano-tag, a streptavidin-binding peptide for the purification and detection of recombinant proteins | Q44697228 | ||
| Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules | Q46830076 | ||
| Engineered two-helix small proteins for molecular recognition | Q47863941 | ||
| Evaluation of epidermal growth factor receptor, carcinoembryonic antigen and Lewis carbohydrate antigens in human colorectal and liver neoplasias | Q73447663 | ||
| Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library | Q33266393 | ||
| Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain | Q33358578 | ||
| Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities | Q33387746 | ||
| Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity | Q33447473 | ||
| Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro | Q33471712 | ||
| Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I. | Q33506664 | ||
| An engineered knottin peptide labeled with 18F for PET imaging of integrin expression | Q33581665 | ||
| Polypeptides from phage display. A superior source of in vivo imaging agents. | Q33701028 | ||
| Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects | Q33708506 | ||
| Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin | Q34083412 | ||
| Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules | Q34134412 | ||
| Alternate protein frameworks for molecular recognition | Q34138708 | ||
| 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors | Q34140651 | ||
| Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein. | Q34417022 | ||
| A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects | Q34419762 | ||
| Peptide radiopharmaceuticals for diagnosis and therapy | Q34422459 | ||
| A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression | Q34435496 | ||
| Arming antibodies: prospects and challenges for immunoconjugates | Q34449555 | ||
| In vitro display technologies reveal novel biopharmaceutics. | Q34551978 | ||
| (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors. | Q34703098 | ||
| Molecular imaging of cancer with positron emission tomography | Q34810431 | ||
| Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine. | Q34976211 | ||
| Molecular imaging in living subjects: seeing fundamental biological processes in a new light | Q35082602 | ||
| Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging | Q36100348 | ||
| [18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography | Q36627997 | ||
| Biopharmaceutical drug discovery using novel protein scaffolds | Q36630407 | ||
| TEM-1 beta-lactamase as a scaffold for protein recognition and assay | Q36639409 | ||
| Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules | Q36922818 | ||
| Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules | Q37453801 | ||
| Mutagenesis and selection of PDZ domains that bind new protein targets. | Q38327524 | ||
| On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model. | Q39882876 | ||
| Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry | Q39891849 | ||
| Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake. | Q39966231 | ||
| Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. | Q39991878 | ||
| SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression | Q40009259 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 1037-1047 | |
| P577 | publication date | 2010-02-21 | |
| P1433 | published in | Amino Acids | Q15757015 |
| P1476 | title | Protein scaffold-based molecular probes for cancer molecular imaging | |
| P478 | volume | 41 |
| Q36085489 | 68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET |
| Q37714107 | 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging |
| Q28072407 | A current perspective on applications of macrocyclic-peptide-based high-affinity ligands |
| Q38985097 | A novel Affibody bioconjugate for dual-modality imaging of ovarian cancer |
| Q36585770 | Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging |
| Q37730252 | Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. |
| Q34545516 | Affibody-based nanoprobes for HER2-expressing cell and tumor imaging |
| Q58859498 | Analytical applications of affibodies |
| Q36333938 | Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis |
| Q30470859 | Cardiovascular molecular imaging: focus on clinical translation |
| Q26781607 | Challenges and opportunities for non-antibody scaffold drugs |
| Q38137253 | Design and evaluation of radiolabeled tracers for tumor imaging |
| Q36254454 | Designed hydrophilic and charge mutations of the fibronectin domain: towards tailored protein biodistribution |
| Q28543140 | Desired alteration of protein affinities: competitive selection of protein variants using yeast signal transduction machinery |
| Q45107054 | Engineering and functionalization of the disulfide-constrained miniprotein min-23 as a scaffold for diagnostic application |
| Q31032588 | Engineering bispecificity into a single albumin-binding domain |
| Q28541561 | Engineering of bispecific affinity proteins with high affinity for ERBB2 and adaptable binding to albumin |
| Q55257427 | Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding. |
| Q36845960 | Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes |
| Q37641853 | Near-infrared quantum dots for HER2 localization and imaging of cancer cells |
| Q37225316 | New strategy for monitoring targeted therapy: molecular imaging |
| Q93116555 | Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3 |
| Q35641937 | PET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides |
| Q34429075 | PET of EGFR expression with an 18F-labeled affibody molecule |
| Q39620629 | Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy |
| Q35501293 | Protein and peptide probes for molecular imaging |
| Q35571891 | Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity |
| Q51353652 | Small-Protein-Stabilized Semiconductor Nanoprobe for Targeted Imaging of Cancer Cells. |
| Q58726271 | The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment |
| Q37996849 | The role of nuclear medicine in modern therapy of cancer |
Search more.